Century Therapeutics Ratios (2020-2026) | IPSC

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-3,544.14%-2,218.48%-1,381.47%-6,074.86%-1,747.44%-32,667.68%-21,708.11%-15,025.00%-3,281.99%-4,044.75%-3,948.67%-821.88%70.13%
EBIT Margin (Quarter)
-3,538.37%-2,245.77%-1,427.07%-6,392.71%-1,865.17%-35,431.31%-24,071.62%-16,329.10%-3,661.87%-4,507.78%-4,398.10%1,789.96%67.95%
EBITDA Margin (Quarter)
-3,733.93%-2,276.50%-1,390.24%-5,861.80%-1,748.66%-33,558.59%-22,173.65%-14,173.13%-3,322.92%-4,056.42%-3,812.77%-874.84%70.12%
Operating Margin (Quarter)
-3,538.37%-2,245.77%-1,427.07%-6,392.71%-1,865.17%-35,431.31%-24,071.62%-16,329.10%-3,661.87%-4,507.78%-4,398.10%1,789.96%67.95%
Net Margin (Quarter)
-3,545.65%-2,219.77%-1,382.60%-6,080.04%-1,817.21%-33,627.27%-22,108.11%-14,701.87%-3,282.11%-4,047.60%-3,947.66%-843.59%70.13%
FCF Margin (Quarter)
7,840.93%-1,581.16%-2,170.01%-235.12%-1,988.95%-23,989.90%-11,428.38%-10,152.99%-3,600.82%-3,579.38%-3,581.80%-580.47%-32.15%
Efficiency
Assets Average (Quarter)
482.68M453.55M493.84M541.45M522.17M499.15M471.39M436.69M407.36M379.12M354.60M382.48M402.53M370.92M334.41M300.15M264.70M234.21M275.13M
Equity Average (Quarter)
178.02M435.29M409.61M391.45M372.31M344.08M316.47M289.96M262.37M233.40M201.99M181.32M199.99M208.90M178.52M200.90M225.17M193.12M167.64M211.84M
Invested Capital (Quarter)
457.38M432.99M397.28M386.66M359.55M334.24M309.24M287.47M247.57M219.23M184.75M177.88M222.10M195.69M161.36M240.44M209.90M184.69M162.69M266.68M
Asset Utilization Ratio (Quarter)
0.010.010.010.010.010.000.010.010.020.340.380.430.47
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-72.39-80.21-87.14-119.22-95.00-107.22-51.80-92.19-257.92
Debt to Equity (Quarter)
0.030.030.030.030.030.040.050.020.01
Debt Ratio (Quarter)
0.020.020.020.020.020.020.030.020.01
Equity Ratio (Quarter)
0.900.900.910.700.670.650.620.610.590.550.510.510.530.500.460.760.740.720.710.81
Times Interest Earned (Quarter)
-72.39-80.21-87.14-119.22-95.00-107.22-51.80-92.19-257.92
Valuation
Enterprise Value (Quarter)
-397.57M-295.15M-222.88M-361.02M-378.76M-355.86M-315.50M-251.47M-156.40M-169.50M-172.74M-192.02M-196.40M-198.11M-189.29M-293.37M-155.84M-204.20M-168.55M-134.80M
Return Ratios
Return on Sales (Quarter)
-0.35%-0.22%-0.14%-0.61%-0.18%-3.36%-2.21%-1.47%-0.33%-0.40%-0.39%-0.08%0.01%0.00%0.00%0.00%
Return on Capital Employed (Quarter)
-17.75%-21.67%-24.21%-23.58%-25.95%-28.52%-28.96%-31.66%-35.17%-40.56%-43.06%-40.03%-37.79%-10.85%24.80%27.85%32.18%-0.94%-38.19%
Return on Invested Capital (Quarter)
0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%